![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 471/04 | (2006.01) |
C07D 519/00 | (2013.01) | ||
C07D 519/00 | (2006.01) | ||
C07D 471/04 | (2013.01) |
(11) | Number of the document | 3849977 |
(13) | Kind of document | T |
(96) | European patent application number | 19769738.6 |
Date of filing the European patent application | 2019-09-10 | |
(97) | Date of publication of the European application | 2021-07-21 |
(45) | Date of publication and mention of the grant of the patent | 2023-07-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2019/074083 |
Date | 2019-09-10 |
(87) | Number | WO 2020/053198 |
Date | 2020-03-19 |
(30) | Number | Date | Country code |
PCT/CN2018/104941 | 2018-09-11 | WO |
(72) |
TURNER, Andrew, Roy , GB
TURNER, Andrew, Timothy , GB
HOWELL, Gareth, Paul , GB
GALL, Malcolm, Allan, Young , GB
MULHOLLAND, Keith, Raymond , GB
ADLINGTON, Neil, Keith , GB
TIAN, Zhenping , CN
LIU, Bo , CN
GONG, Qisun , CN
YU, Wei , CN
|
(73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
Hutchison Medipharma Limited , Building 4 720 Cai Lun Road Pilot Free Zone, Shanghai 201203, CN |
(54) | IMPROVED METHOD FOR THE MANUFACTURE OF 3-[(1S)-1-IMIDAZO[1,2-A]PYRIDIN-6-YLETHYL]-5-(1-METHYLPYRAZOL-4-YL)TRIAZOLO[4,5-B]PYRAZINE AND POLYMORPHIC FORMS THEREOF |
IMPROVED METHOD FOR THE MANUFACTURE OF 3-[(1S)-1-IMIDAZO[1,2-A]PYRIDIN-6-YLETHYL]-5-(1-METHYLPYRAZOL-4-YL)TRIAZOLO[4,5-B]PYRAZINE AND POLYMORPHIC FORMS THEREOF |